SARA KARL-LUSARDI: Open Payments
NPI 1053995944 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,664 in 81 payments from 22 companies in 2025. Trend: 2023 $770 · 2024 $1,265 · 2025 $2,664
Food & beverage: $1,655Travel & lodging: $1,010
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 14 | $1,378 |
| E.R. Squibb & Sons, L.L.C. | 13 | $215 |
| Novo Nordisk Inc | 8 | $162 |
| PFIZER INC. | 5 | $105 |
| Merck Sharp & Dohme LLC | 4 | $103 |
| Amgen Inc. | 5 | $102 |
| Alnylam Pharmaceuticals Inc. | 5 | $94 |
| BridgeBio Pharma, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Lilly USA, LLC | 4 | $70 |
Products named: SYMPLICITY G3, CAMZYOS, Wegovy, VYNDAQEL, REPATHA, VERQUVO, AURORA EV-ICD MRI SURESCAN, Attruby.
Industry payments across MI — which companies pay providers there.
